{"id":"rosuvastatin-and-ezetimibe","safety":{"commonSideEffects":[{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Elevated liver enzymes"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Gastrointestinal disturbance"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Rosuvastatin is a statin that reduces cholesterol synthesis in the liver by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol production. Ezetimibe selectively inhibits cholesterol absorption in the small intestine by blocking the Niemann-Pick C1-like 1 (NPC1L1) transporter. Together, they provide complementary mechanisms to reduce both endogenous cholesterol production and dietary cholesterol uptake, resulting in greater LDL-C lowering than either agent alone.","oneSentence":"Rosuvastatin inhibits HMG-CoA reductase to lower LDL cholesterol, while ezetimibe blocks intestinal cholesterol absorption, providing dual lipid-lowering action.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:05:59.011Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia and dyslipidemia"},{"name":"Cardiovascular risk reduction in patients requiring additional LDL-C lowering"}]},"trialDetails":[{"nctId":"NCT07474649","phase":"PHASE3","title":"A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events","status":"NOT_YET_RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2026-06-01","conditions":"Coronary Atherosclerosis, Mixed Dyslipidemia, Hypercholesterolemia","enrollment":103},{"nctId":"NCT07359105","phase":"NA","title":"Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)","status":"RECRUITING","sponsor":"Sin Gon Kim","startDate":"2026-03-09","conditions":"Dyslipidemia Associated With Type II Diabetes Mellitus","enrollment":2186},{"nctId":"NCT06686615","phase":"","title":"A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia","status":"RECRUITING","sponsor":"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company","startDate":"2025-02-12","conditions":"Primary Hypercholesterolemiia, Mixed Dyslipidemia","enrollment":2000},{"nctId":"NCT07432516","phase":"NA","title":"Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2026-02","conditions":"Coronary Artery Disease","enrollment":4400},{"nctId":"NCT07307989","phase":"PHASE2","title":"Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-08-01","conditions":"Ischemic Stroke, Hypercholesteremia","enrollment":300},{"nctId":"NCT06501443","phase":"PHASE4","title":"LATAM LOWERS LDL-C","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-11","conditions":"Hypercholesterolaemia","enrollment":520},{"nctId":"NCT07201545","phase":"PHASE1","title":"Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-10-07","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT06896708","phase":"NA","title":"Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome","status":"RECRUITING","sponsor":"Liu yong","startDate":"2025-08-12","conditions":"Chronic Coronary Syndrome","enrollment":766},{"nctId":"NCT07182383","phase":"PHASE1","title":"Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-09-29","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT06317051","phase":"PHASE3","title":"Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kirby Institute","startDate":"2024-12-16","conditions":"HIV Infections, Weight Gain","enrollment":300},{"nctId":"NCT07255820","phase":"PHASE4","title":"Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol","status":"NOT_YET_RECRUITING","sponsor":"Bahria University","startDate":"2026-01-01","conditions":"Type 2 Diabetes Mellitus, Hypercholesterolemia / Elevated LDL Cholesterol","enrollment":126},{"nctId":"NCT05910476","phase":"PHASE4","title":"Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yonsei University","startDate":"2023-05-03","conditions":"Coronary Artery Disease, Dyslipidemias","enrollment":200},{"nctId":"NCT04626973","phase":"NA","title":"Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2021-01-15","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":3048},{"nctId":"NCT06742853","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-12-20","conditions":"Dyslipidemia","enrollment":81},{"nctId":"NCT04669041","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2020-12-08","conditions":"Hypercholesterolemia","enrollment":305},{"nctId":"NCT06767345","phase":"PHASE4","title":"Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization","status":"RECRUITING","sponsor":"Korea University Anam Hospital","startDate":"2025-05-12","conditions":"Coronary Artery Disease, Atherosclerosis of Coronary Artery, Plaque, Atherosclerotic","enrollment":408},{"nctId":"NCT05889143","phase":"","title":"A Study to Evaluate the Efficacy and Safety of CREZET Tablet","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2023-05-24","conditions":"Dyslipidemias","enrollment":15000},{"nctId":"NCT04700436","phase":"PHASE4","title":"Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2020-01-03","conditions":"Endocrine System Diseases, Nutritional and Metabolic Diseases, Diabetes Mellitus, Type 2","enrollment":146},{"nctId":"NCT07083206","phase":"","title":"A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe","status":"RECRUITING","sponsor":"Ahn-Gook Pharmaceuticals Co.,Ltd","startDate":"2025-07-29","conditions":"Hypercholesterolemia, Dyslipidemias","enrollment":4500},{"nctId":"NCT03169985","phase":"PHASE4","title":"Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque","status":"ACTIVE_NOT_RECRUITING","sponsor":"Samsung Medical Center","startDate":"2017-07-12","conditions":"Coronary Artery Disease","enrollment":280},{"nctId":"NCT06186037","phase":"PHASE4","title":"Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"Saint Vincent's Hospital, Korea","startDate":"2024-02-01","conditions":"Coronary Artery Disease, Dyslipidemias, Primary Prevention","enrollment":6356},{"nctId":"NCT07036991","phase":"PHASE4","title":"Clinical Trial of PCSK9 Inhibitor and Statin Treatment for Carotid Artery Stenosis","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-07-30","conditions":"Carotid Artery Stenosis","enrollment":406},{"nctId":"NCT06646354","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia","status":"ENROLLING_BY_INVITATION","sponsor":"Hyundai Pharm","startDate":"2025-04-22","conditions":"Hypertension, Primary Hypercholesterolaemia","enrollment":125},{"nctId":"NCT06231966","phase":"NA","title":"Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2024-04-22","conditions":"Peripheral Artery Disease, Polyvascular Disease","enrollment":2462},{"nctId":"NCT05368545","phase":"NA","title":"Influence of Lipid Lowering on Impaired Coronary Flow","status":"COMPLETED","sponsor":"Aarhus University Hospital","startDate":"2020-05-15","conditions":"Coronary Artery Disease","enrollment":109},{"nctId":"NCT06604117","phase":"","title":"Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-10-17","conditions":"Ischemic Stroke, Atherosclerosis of Artery, Lipid Disorder","enrollment":200},{"nctId":"NCT05661552","phase":"PHASE4","title":"Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2022-12-01","conditions":"Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia","enrollment":108},{"nctId":"NCT05845424","phase":"PHASE4","title":"High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2023-07-03","conditions":"Coronary Artery Calcification, Metabolic Syndrome, Dyslipidemias","enrollment":6000},{"nctId":"NCT04656028","phase":"NA","title":"Genetic Testing and Motivational Counseling for FH","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Medical Research Center for Therapy and Preventive Medicine","startDate":"2020-06-15","conditions":"Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2","enrollment":180},{"nctId":"NCT03993236","phase":"PHASE4","title":"Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke","status":"COMPLETED","sponsor":"Keun-Sik Hong","startDate":"2019-09-09","conditions":"Stroke, Ischemic","enrollment":584},{"nctId":"NCT06578676","phase":"PHASE1","title":"To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults","status":"RECRUITING","sponsor":"Hyundai Pharm","startDate":"2024-06-20","conditions":"Type 2 Diabetes, Dyslipidemias","enrollment":56},{"nctId":"NCT00090298","phase":"PHASE3","title":"Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-04","conditions":"Hypercholesterolemia","enrollment":2815},{"nctId":"NCT00651378","phase":"PHASE4","title":"Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2004-09-01","conditions":"Hypercholesterolemia, Atherosclerosis, Coronary Artery Disease","enrollment":87},{"nctId":"NCT00871351","phase":"PHASE4","title":"Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2009-02-01","conditions":"Primary Hypercholesterolemia","enrollment":125},{"nctId":"NCT02741245","phase":"PHASE3","title":"A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2016-06-09","conditions":"Hypercholesterolemia","enrollment":321},{"nctId":"NCT02748057","phase":"PHASE3","title":"A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2016-05-18","conditions":"Hypercholesterolemia, Familial Hypercholesterolemia","enrollment":135},{"nctId":"NCT00462748","phase":"PHASE3","title":"A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-03","conditions":"Hypercholesterolemia","enrollment":786},{"nctId":"NCT00479713","phase":"PHASE3","title":"A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02-01","conditions":"Hypercholesterolemia","enrollment":618},{"nctId":"NCT00862251","phase":"PHASE3","title":"Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2009-04","conditions":"Cardiovascular Disorder, Diabetes Mellitus","enrollment":808},{"nctId":"NCT00783263","phase":"PHASE3","title":"A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-11","conditions":"Hypercholesterolemia","enrollment":440},{"nctId":"NCT04968509","phase":"PHASE3","title":"Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2024-03-22","conditions":"Aortic Stenosis","enrollment":160},{"nctId":"NCT06225635","phase":"PHASE1","title":"A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab","status":"COMPLETED","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2022-01-01","conditions":"Hyperlipidemias","enrollment":60},{"nctId":"NCT05624658","phase":"NA","title":"Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS","status":"UNKNOWN","sponsor":"Samara Regional Cardiology Dispensary","startDate":"2022-09-02","conditions":"Dyslipidemias","enrollment":200},{"nctId":"NCT06096909","phase":"NA","title":"Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population","status":"NOT_YET_RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-11-01","conditions":"Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome","enrollment":3684},{"nctId":"NCT04826354","phase":"PHASE4","title":"Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2021-08-11","conditions":"Atheroscleroses, Coronary","enrollment":582},{"nctId":"NCT05884502","phase":"PHASE4","title":"A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke","status":"UNKNOWN","sponsor":"Korea University Anam Hospital","startDate":"2022-09-01","conditions":"Dyslipidemias, Stroke, Acute Ischemic","enrollment":330},{"nctId":"NCT03510884","phase":"PHASE3","title":"An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-05-31","conditions":"Hypercholesterolaemia","enrollment":153},{"nctId":"NCT03947866","phase":"","title":"Ezetimibe-Rosuvastatin Evaluation Study","status":"UNKNOWN","sponsor":"Elpen Pharmaceutical Co. Inc.","startDate":"2022-09-30","conditions":"Hypercholesterolemia, Hyperlipidemias, Combinations of Drugs; Dependence","enrollment":600},{"nctId":"NCT04895098","phase":"","title":"Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD","status":"COMPLETED","sponsor":"Akrikhin","startDate":"2021-06-23","conditions":"Lipid Metabolism Disorders, Cardiovascular Diseases","enrollment":1000},{"nctId":"NCT01763866","phase":"PHASE3","title":"LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2","status":"COMPLETED","sponsor":"Amgen","startDate":"2013-01-15","conditions":"Hyperlipidemia","enrollment":2067},{"nctId":"NCT03847506","phase":"PHASE4","title":"Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets","status":"COMPLETED","sponsor":"HK inno.N Corporation","startDate":"2018-07-05","conditions":"Hypertension, Hyperlipidemia","enrollment":127},{"nctId":"NCT01047501","phase":"PHASE3","title":"Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2009-12","conditions":"Hypertriglyceridemia","enrollment":702},{"nctId":"NCT01047683","phase":"PHASE3","title":"Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2009-12","conditions":"Hypertriglyceridemia","enrollment":229},{"nctId":"NCT01492361","phase":"PHASE3","title":"A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2011-11","conditions":"Cardiovascular Diseases","enrollment":8179},{"nctId":"NCT02476006","phase":"PHASE3","title":"Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-06-23","conditions":"Hypercholesterolemia","enrollment":998},{"nctId":"NCT00651144","phase":"PHASE1","title":"Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-03","conditions":"Hypercholesterolemia, Atherosclerosis","enrollment":40},{"nctId":"NCT00730132","phase":"","title":"Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-01","conditions":"Coronary Heart Disease, Hypercholesterolemia","enrollment":712},{"nctId":"NCT01154036","phase":"PHASE3","title":"MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-07","conditions":"Hypercholesterolemia","enrollment":1547},{"nctId":"NCT04895059","phase":"PHASE1","title":"Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2017-04-30","conditions":"Healthy","enrollment":36},{"nctId":"NCT03355027","phase":"NA","title":"Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease","status":"UNKNOWN","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2017-11-30","conditions":"Atherosclerosis, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT03434613","phase":"PHASE4","title":"Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2018-05-14","conditions":"Nonalcoholic Fatty Liver Disease, Dyslipidemias","enrollment":64},{"nctId":"NCT04158076","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2020-01-23","conditions":"Hypercholesterolemia, Hypertension","enrollment":131},{"nctId":"NCT04829149","phase":"","title":"Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2016-06-14","conditions":"Dyslipidemias","enrollment":5717},{"nctId":"NCT04737408","phase":"PHASE3","title":"Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)","status":"UNKNOWN","sponsor":"Bjarne Linde Noergaard","startDate":"2020-05-13","conditions":"Coronary Artery Disease","enrollment":120},{"nctId":"NCT02772640","phase":"PHASE4","title":"Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe","status":"COMPLETED","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2016-03","conditions":"Hypercholesterolemia","enrollment":83},{"nctId":"NCT03872232","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2019-02-26","conditions":"Hypercholesterolemia, Hypertension","enrollment":180},{"nctId":"NCT04433533","phase":"PHASE4","title":"Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2021-01-06","conditions":"Left Ventricular Diastolic Dysfunction, Hyperlipidemias","enrollment":200},{"nctId":"NCT03510715","phase":"PHASE3","title":"An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-08-31","conditions":"Hypercholesterolemia","enrollment":18},{"nctId":"NCT03403556","phase":"PHASE4","title":"High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Yuhan Corporation","startDate":"2018-03-27","conditions":"Atherosclerotic Cardiovascular Disease, Type 2 Diabetes","enrollment":140},{"nctId":"NCT03597412","phase":"PHASE4","title":"Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-10-17","conditions":"Atherosclerotic Cardiovascular Disease, Type 2 Diabetes Mellitus","enrollment":236},{"nctId":"NCT04659070","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia","status":"UNKNOWN","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2020-07-15","conditions":"Primary Hypercholesterolemia, Hypertension","enrollment":156},{"nctId":"NCT04074551","phase":"PHASE3","title":"A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2019-07-16","conditions":"Hypertension, Dyslipidemias","enrollment":145},{"nctId":"NCT04455581","phase":"PHASE2","title":"A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2020-09-01","conditions":"Familial Hypercholesterolemia","enrollment":8},{"nctId":"NCT01730053","phase":"PHASE3","title":"Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2012-11-30","conditions":"Hypercholesterolemia","enrollment":305},{"nctId":"NCT04322266","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-12-21","conditions":"Healthy","enrollment":61},{"nctId":"NCT04080310","phase":"PHASE4","title":"Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2018-03-15","conditions":"Cardiovascular Diseases","enrollment":270},{"nctId":"NCT01420549","phase":"PHASE3","title":"Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia","status":"COMPLETED","sponsor":"Ache Laboratorios Farmaceuticos S.A.","startDate":"2013-03","conditions":"Hypercholesterolemia, Dyslipidemia","enrollment":129},{"nctId":"NCT03494270","phase":"PHASE4","title":"High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-03-18","conditions":"ASCVD","enrollment":270},{"nctId":"NCT04185090","phase":"PHASE1","title":"To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults","status":"UNKNOWN","sponsor":"IlDong Pharmaceutical Co Ltd","startDate":"2020-02","conditions":"Hypertension, Dyslipidemias","enrollment":30},{"nctId":"NCT04161001","phase":"PHASE3","title":"Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451","status":"UNKNOWN","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2019-11-20","conditions":"Hypertension, Dyslipidemia","enrollment":237},{"nctId":"NCT02715726","phase":"PHASE3","title":"Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-07-27","conditions":"Hypercholesterolemia","enrollment":615},{"nctId":"NCT03217409","phase":"PHASE4","title":"A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-08-10","conditions":"Diabetes Mellitus and Hypercholesterolemia","enrollment":85},{"nctId":"NCT01890967","phase":"PHASE2","title":"A Study of LY3015014 in Participants With High Cholesterol","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-06","conditions":"Hypercholesterolemia","enrollment":527},{"nctId":"NCT04081844","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-05-03","conditions":"Healthy","enrollment":31},{"nctId":"NCT02984982","phase":"PHASE4","title":"Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-11-15","conditions":"Hypercholesterolemia, Acute Coronary Syndrome","enrollment":206},{"nctId":"NCT04061824","phase":"PHASE4","title":"Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2016-05-24","conditions":"Hypertension, Dyslipidemias","enrollment":150},{"nctId":"NCT04056169","phase":"PHASE4","title":"Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-06-29","conditions":"Acute Coronary Syndrome, Carotid Atherosclerotic Plaque With Inflammation","enrollment":50},{"nctId":"NCT03446261","phase":"PHASE4","title":"Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-02-23","conditions":"Type 2 Diabetes Mellitus, Hypercholesterolemia","enrollment":140},{"nctId":"NCT03532854","phase":"PHASE1","title":"Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802","status":"COMPLETED","sponsor":"LG Chem","startDate":"2018-05-28","conditions":"Healthy Male Volunteers","enrollment":42},{"nctId":"NCT03044665","phase":"NA","title":"RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2017-03-15","conditions":"Cardiovascular Diseases, Cerebrovascular Disease, Peripheral Atherosclerotic Disease","enrollment":3780},{"nctId":"NCT03571087","phase":"PHASE3","title":"Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2014-09","conditions":"Primary Hypercholesterolemia","enrollment":374},{"nctId":"NCT02749994","phase":"PHASE3","title":"A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)","status":"COMPLETED","sponsor":"IlDong Pharmaceutical Co Ltd","startDate":"2016-04","conditions":"Hypercholesterolemia","enrollment":396},{"nctId":"NCT03288038","phase":"PHASE3","title":"The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia","status":"COMPLETED","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2014-10-13","conditions":"Hypercholesterolemia","enrollment":382},{"nctId":"NCT02127320","phase":"PHASE1","title":"Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2014-06","conditions":"Healthy","enrollment":24},{"nctId":"NCT01644188","phase":"PHASE3","title":"Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2012-08","conditions":"Hypercholesterolemia","enrollment":720},{"nctId":"NCT02029625","phase":"PHASE1","title":"Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe","status":"COMPLETED","sponsor":"NVP Healthcare","startDate":"2014-02","conditions":"Dyslipidemia","enrollment":41},{"nctId":"NCT02289430","phase":"PHASE1","title":"to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers","status":"COMPLETED","sponsor":"NVP Healthcare","startDate":"2014-12","conditions":"Healthy","enrollment":59},{"nctId":"NCT00908011","phase":"NA","title":"Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2009-06","conditions":"Hypercholesterolemia, HIV Infections","enrollment":43},{"nctId":"NCT01730040","phase":"PHASE3","title":"Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2012-10","conditions":"Hypercholesterolemia","enrollment":355},{"nctId":"NCT02445352","phase":"PHASE3","title":"Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia","status":"COMPLETED","sponsor":"Alvogen Korea","startDate":"2014-07","conditions":"Primary Hypercholesterolemia","enrollment":379}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ACUTE KIDNEY INJURY"},{"count":1,"reaction":"ASTHENIA"},{"count":1,"reaction":"BALANCE DISORDER"},{"count":1,"reaction":"ERYTHEMA"},{"count":1,"reaction":"HYPERKALAEMIA"},{"count":1,"reaction":"METABOLIC ACIDOSIS"}],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Crestor and Ezetrol"],"phase":"marketed","status":"active","brandName":"Rosuvastatin and Ezetimibe","genericName":"Rosuvastatin and Ezetimibe","companyName":"Hanmi Pharmaceutical Company Limited","companyId":"hanmi-pharmaceutical-company-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Rosuvastatin inhibits HMG-CoA reductase to lower LDL cholesterol, while ezetimibe blocks intestinal cholesterol absorption, providing dual lipid-lowering action. Used for Hypercholesterolemia and dyslipidemia, Cardiovascular risk reduction in patients requiring additional LDL-C lowering.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}